* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Right heart catheterisation: how to avoid the most common mistakes
Heart failure wikipedia , lookup
Myocardial infarction wikipedia , lookup
Coronary artery disease wikipedia , lookup
Lutembacher's syndrome wikipedia , lookup
Cardiac surgery wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Atrial septal defect wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
Right heart catheterisation: how to avoid the most common mistakes Dr. Michele D'Alto Department of Cardiology Second University of Naples Monaldi Hospital Via Leonardo Bianchi, 1 80131 Naples ITALY [email protected] AIMS To discuss practical issues: vein cannulation, type of catheter, catheter placement, waveform interpretation, measurements and calculations. To identify possible pitfalls and caveat. To improve the skills in performing a correct diagnosis integrating RHC and other imaging modalities. SUMMARY Right heart catheterization (RHC) represents the gold standard for measuring pulmonary haemodynamics. RHC is mandatory to confirm the diagnosis of pulmonary hypertension (PH), to assess the severity of haemodynamic impairment and to perform vasoreactivity testing in selected patients. PH is defined as a mean pulmonary arterial pressure (mPAP) ≥25 mmHg by RHC measured at rest, with pre-capillary PH being defined by a pulmonary artery wedge pressure (PAWP) ≤15 mmHg and post-capillary PH by a PAWP >15 mmHg. Among post-capillary PH, “isolated post-capillary PH” (Ipc-PH) is defined by a diastolic pulmonary gradient (DPG) <7 mmHg and pulmonary vascular resistance (PVR) ≤3 WU, and “combined post- and pre-capillary PH” (Cpc-PH) by DPG ≥7 mmHg and/or PVR >3 WU. The term pulmonary arterial hypertension (PAH) describes a group of PH characterized by the presence of pre-capillary PH and a pulmonary vascular resistance (PVR) >3 Wood units (WU) in the absence of other causes of pre-capillary PH such as PH due to lung diseases, chronic thromboembolic pulmonary hypertension (CTEPH) or other rare diseases. RHC, as an invasive diagnostic tool, is part of a complex alghorhythm for PH diagnosis. The interpretation of invasive haemodynamics should consider the context of the clinical picture and imaging, in particular echocardiography. RHC is a challenging procedure requiring careful attention, meticulous measurement and extensive expertise. In order to obtain valuable clinical information and to minimize the risk related to the procedure RHC should be limited to expert centres. Cannulation of a sufficiently large systemic vein is the first step for performing RHC. The practice of using surface anatomy and palpation to identify target vessels before cannulation attempts (“landmark technique”) is based on the supposed location of the vessel, the identification of anatomic landmarks, and blind insertion of the needle until blood is aspirated. Depending on the site and patient population, landmark techniques for vascular cannulation are associated with a 60% to 95% success rate. The landmark technique can be augmented by the use of ultrasound; this is recommended in the case of jugular vein cannulation and very helpful when using the brachial vein approach. The gold standard for pressure and blood flow measurement of the pulmonary circulation are respectively the high-fidelity micromanometer-tipped catheters and the direct Fick method. The fluidfilled flow-directed thermodilution catheters are much more widely used and have been demonstrated to be accurate though with lack of precision of +/- 1/L/min for cardiac output, +/- 8 mmHg for mPAP and -15 to +8 mmHg for PAWP. Precision on otherwise accurate measurements can be improved by repetition and averaging. This is why it is recommended to average 3 to 5 thermodilution cardiac output measurements with less than 10% variation, and to read pulmonary vascular pressures in triplicate. In clinical practice, the catheter commonly used for RHC is a balloon floatation tip catheter, known as “Swan-Ganz” catheter. A correct zero level set is pivotal in performing RHC. The wrong zero level set is one of the most common mistakes and a major confounding factor during RHC. Zero level setting must be meticulous because it represents the starting point for all pressure measurements. In fact, each pressure measured during RHC is a difference between the pressure at the chosen zero level and the pressure in the chamber (or vessel) where the fluid-filled catheter tip is located, assuming there is no obstruction and no significant flow within the catheter. The question of zero leveling was raised before the introduction of cardiac catheterization, during the early measurements of the peripheral and central venous pressure. An ideal zero reference would be not only independent of chest diameter but also insensitive to changes in body position and represent a “hydrostatic indifference point”. Recently, it has been proposed a standardized reference point valid in any body position, defined by the intersection of the mid-thoracic frontal plane with the transverse plane passing through the fourth anterior intercostal space and the mid-sagittal plane. Kovacs et al. assessed retrospectively the position on computed tomography the right and left atrial centre levels in 196 consecutive patients with PH undergoing RHC, found that the centre of the left atrium was best described by the “mid-thoracic level”. As a consequence, zeroing the system at this level seems reasonable for the assessment of PAWP. Accurate measurement of left ventricular filling pressure is essential to distinguish between PAH and PH due to left heart diseases, mainly heart failure with preserved ejection fraction (HFpEF). Commonly, PAWP is used as a surrogate measure of left atrial pressure and left ventricular enddiastolic pressure. PAWP is the pressure measured from a catheter wedged in a branch pulmonary artery. Actually, the term “wedge pressure” derives from the measurement obtained by a “wedged” catheter without an inflated balloon. Using an inflated balloon we measure a “pulmonary artery occluded pressure”. Both are usually referred to as a PAWP and used indifferently, but the measured pressures will be different if there is an increased large vein resistance (such as in sepsis for example). In clinical practice, determination of CO and CI is typically done by either the Fick method or thermodilution, in order of reproducibility the direct Fick is preferable to thermodilution which is in turn preferable to the indirect Fick. The Fick principle is based on the observation that the total uptake (or release) of a substance by the peripheral tissues is equal to the product of the blood flow to the peripheral tissues and the arterialvenous concentration difference (gradient) of the substance. In the determination of cardiac output, the substance most commonly measured is the oxygen content of blood thus giving the arterio-venous oxygen difference, and the flow calculated is the flow across the pulmonary system. This provides an easy way to calculate the cardiac output: Cardiac output = oxygen consumption / arteriovenous oxygen difference. Measurement of the arterial and venous oxygen content of blood involves the sampling of blood from the pulmonary artery and from the pulmonary vein. In practice, sampling of peripheral arterial blood is a surrogate for pulmonary venous blood. The first step during RHC in congenital heart disease is to obtain pressure measurements at different levels of the systemic venous return, the right heart, and the pulmonary circulation. This should include measurements in the superior vena cava, inferior vena cava, right atrium, right ventricle (or sub-pulmonary ventricle), pulmonary artery, and PAWP. Systemic pressures are also required to calculate the ratio between pulmonary and systemic artery pressure. The ratio between the systemic and pulmonary pressures and resistance may be especially useful if shunt closure is contemplated. RHC in patients with pulmonary hypertension can be very challenging and has been associated with serious, sometimes fatal, complications. For this reason, RHC should be performed only in expert centres. REFERENCES 1. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M; Authors/Task Force Members. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2015 Aug 29. pii: ehv317. [Epub ahead of print] 2. Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jaı¨s X, Marinelli A, Barst RJ, Ghofrani HA, Jing ZC, Opitz C, Seyfarth HJ, Halank M, McLaughlin V, Oudiz RJ, Ewert R, Wilkens H, Kluge S, Bremer HC, Baroke E, Rubin LJ. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006;48:2546– 2552. 3. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003;348:1123-33. 4. Troianos CA, Hartman GS, Glas KE, Skubas NJ, Eberhardt RT, Walker JD, Reeves ST; Councils on Intraoperative Echocardiography and Vascular Ultrasound of the American Society of Echocardiography. Guidelines for performing ultrasound guided vascular cannulation: recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 2011;24(12):1291-318). 5. Gibbs NC, Gardner RM. Dynamics of invasive pressure monitoring systems: clinical and laboratory evaluation. Heart Lung. 1988;17:43-51. 6. Pagnamenta A, Vanderpool RR, Brimioulle S, et al. Proximal pulmonary arterial obstruction decreases the time constant of the pulmonary circulation and increases right ventricular afterload. J Appl Physiol. 2013;114:1586-1592. 7. Hoeper MM, Maier R, Tongers J, et al. Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension. Am J Respir Crit Care Med 1999;160:535-541. 8. Halpern SD, Taichman DB. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest. 2009;136:37-43. 9. Rich S, D'Alonzo GE, Dantzker DR, et al. Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension. Am J Cardiol. 1985;55:159-163. 10. Kovacs G, Avian A, Pienn M, et al. Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med. 2014;190:252-257). 11. Naeije R, D'Alto M, Forfia PR. Clinical and research measurement techniques of the pulmonary circulation: the present and the future. Prog Cardiovasc Dis 12. Guyton AC, Greganti FP. A physiologic reference point for measuring circulatory pressures in the dog; particularly venous pressure. Am J Physiol 1956; 185: 137–141. 13. McGee SR. Physical examination of venous pressure: a critical review. Am Heart J 1998; 136: 10–18. 14. Moritz F, von Tabora D. U¨bereine Methode, beim Menschen den Druck in oberflachlichen Venen exakt zu bestimmen [A method for determining exact superficial venous pressure in humans]. Deutsches Archiv fur klinische Medizin 1910;98:475–505. 15. Winsor T, Burch G. Phlebostatic axis and phlebostatic level: reference levels for venous pressure measurements in man. Proc Soc Exp Biol Med 1945;58:165–169. 16. Kovacs G, Avian A, Olschewski A, Olschewski H. Zero reference level for right heart Catheterisation. Eur Respir J 2013; 42: 1586–1594. 17. Naeije R, Vachiery JL, Yerly P, Vanderpool R. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J 2013;41:217–23. 18. Gerges M, Gerges C, Lang IM: How to define pulmonary hypertension due to left heart disease. Eur Respir J 2016 and Naeije R 19. Hemnes A: The difficult diagnosis of pulmonary vascular disease in heart failure Eur Respir J 2016 20. Kovacs G, Avian A, Pienn M, Naeije R, Olschewski H. Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med 2014;190:252–257. 21. Halpern SD, Taichman DB. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest 2009;136:37–43. 22. Hoeper MM, Maier R, Tongers J, Niedermeyer J, Hohlfeld JM, Hamm M, Fabel H. Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension. Am J Respir Crit Care Med 1999;160:535–41. 23. Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jaı¨s X, Marinelli A, Barst RJ, Ghofrani HA, Jing ZC, Opitz C, Seyfarth HJ, Halank M, McLaughlin V, Oudiz RJ, Ewert R, Wilkens H, Kluge S, Bremer HC, Baroke E, Rubin LJ. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006;48:25462552.